Long noncoding RNA profiles identify five distinct molecular subtypes of colorectal cancer with clinical relevance

Molecular Oncology

Volumn 8, Issue 8, 2014, Pages 1393-1403

  Chen, Haoyan ^a   Xu, Jie ^a   Hong, Jie ^a   Tang, Ruqi ^a   Zhang, Xi ^b   Fang, Jing Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colorectal cancer; Consensus clustering; Gene expression profiling; Gene set enrichment analysis; LncRNA; Somatic copy number alterations; Survival

Indexed keywords

BIOLOGICAL MARKER; LONG UNTRANSLATED RNA;

ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLASSIFIER; CLUSTER ANALYSIS; COLORECTAL CANCER; COPY NUMBER VARIATION; FEMALE; GENE DELETION; GENE DISRUPTION; GENE DOSAGE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION; SOMATIC COPY NUMBER ALTERATION;

EID: 84911966508     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2014.05.010     Document Type: Article

References (55)

1. Akavia U.D., Litvin O., Kim J., Sanchez-Garcia F., Kotliar D., Causton H.C., Pochanard P., Mozes E., Garraway L.A., Pe'er D. An integrated approach to uncover drivers of cancer. Cell 2010, 143:1005-1017.
2. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y.J., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463:899-905.
3. Brunet J.P., Tamayo P., Golub T.R., Mesirov J.P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4164-4169.
4. Budinska E., Popovici V., Tejpar S., D'Ario G., Lapique N., Sikora K.O., Di Narzo A.F., Yan P., Hodgson J.G., Weinrich S., Bosman F., Roth A., Delorenzi M. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J.Pathology 2013, 231:63-76.
5. De Sousa E.M.F., Wang X., Jansen M., Fessler E., Trinh A., de Rooij L.P., de Jong J.H., de Boer O.J., van Leersum R., Bijlsma M.F., Rodermond H., van der Heijden M., van Noesel C.J., Tuynman J.B., Dekker E., Markowetz F., Medema J.P., Vermeulen L. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat. Medicine 2013, 19:614-618.
6. Dotan E., Cohen S.J. Challenges in the management of stage II colon cancer. Semin. Oncology 2011, 38:511-520.
7. Du Z., Fei T., Verhaak R.G., Su Z., Zhang Y., Brown M., Chen Y., Liu X.S. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat. Struct. Molecular Biol. 2013, 20:908-913.
8. Farina-Sarasqueta A., van Lijnschoten G., Moerland E., Creemers G.J., Lemmens V.E., Rutten H.J., van den Brule A.J. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients. Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol./ESMO 2010, 21:2396-2402.
9. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., Beroukhim R., Milner D.A., Granter S.R., Du J., Lee C., Wagner S.N., Li C., Golub T.R., Rimm D.L., Meyerson M.L., Fisher D.E., Sellers W.R. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005, 436:117-122.
10. Ge X., Chen Y., Liao X., Liu D., Li F., Ruan H., Jia W. Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer. Med. Oncol. 2013, 30:588.
11. Gibb E.A., Brown C.J., Lam W.L. The functional role of long non-coding RNA in human carcinomas. Mol. Cancer 2011, 10:38.
12. Gill S., Loprinzi C.L., Sargent D.J., Thome S.D., Alberts S.R., Haller D.G., Benedetti J., Francini G., Shepherd L.E., Francois Seitz J., Labianca R., Chen W., Cha S.S., Heldebrant M.P., Goldberg R.M. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?. J.Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2004, 22:1797-1806.
13. Graudens E., Boulanger V., Mollard C., Mariage-Samson R., Barlet X., Gremy G., Couillault C., Lajemi M., Piatier-Tonneau D., Zaborski P., Eveno E., Auffray C., Imbeaud S. Deciphering cellular states of innate tumor drug responses. Genome Biol. 2006, 7:R19.
14. Hessels D., Klein Gunnewiek J.M., van Oort I., Karthaus H.F., van Leenders G.J., van Balken B., Kiemeney L.A., Witjes J.A., Schalken J.A. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 2003, 44:8-15. Discussion 15-16.
15. Hoshida Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PloS One 2010, 5:e15543.
16. Hu Y., Chen H.Y., Yu C.Y., Xu J., Wang J.L., Qian J., Zhang X., Fang J.Y. A long non-coding RNA signature to improve prognosis prediction of colorectal cancer. Oncotarget 2014, 5:2230-2242.
17. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8:118-127.
18. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., Tanaka F., Shibata K., Suzuki A., Komune S., Miyano S., Mori M. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 2011, 71:6320-6326.
19. Kosinski C., Li V.S., Chan A.S., Zhang J., Ho C., Tsui W.Y., Chan T.L., Mifflin R.C., Powell D.W., Yuen S.T., Leung S.Y., Chen X. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:15418-15423.
20. Laiho P., Kokko A., Vanharanta S., Salovaara R., Sammalkorpi H., Jarvinen H., Mecklin J.P., Karttunen T.J., Tuppurainen K., Davalos V., Schwartz S., Arango D., Makinen M.J., Aaltonen L.A. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 2007, 26:312-320.
21. Li L., Sun R., Liang Y., Pan X., Li Z., Bai P., Zeng X., Zhang D., Zhang L., Gao L. Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer. J.Exp. Clin. Cancer Res.: CR 2013, 32:104.
22. Li R., Qian J., Wang Y.Y., Zhang J.X., You Y.P. Long noncoding RNA profiles reveal three molecular subtypes in Glioma. CNS Neurosci. Therap. 2014, 20:339-343.
23. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
24. Lipovich L., Johnson R., Lin C.Y. MacroRNA underdogs in a microRNA world: evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA. Biochim. Biophys. Acta 2010, 1799:597-615.
25. Marisa L., de Reynies A., Duval A., Selves J., Gaub M.P., Vescovo L., Etienne-Grimaldi M.C., Schiappa R., Guenot D., Ayadi M., Kirzin S., Chazal M., Flejou J.F., Benchimol D., Berger A., Lagarde A., Pencreach E., Piard F., Elias D., Parc Y., Olschwang S., Milano G., Laurent-Puig P., Boige V. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013, 10:e1001453.
26. McMillan D.C., McArdle C.S., Morrison D.S. A clinical risk score to predict 3-, 5- and 10-year survival in patients undergoing surgery for Dukes B colorectal cancer. Br. J. Cancer 2010, 103:970-974.
27. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 2009, 10:155-159.
28. Merico D., Isserlin R., Stueker O., Emili A., Bader G.D. Enrichment map: a network-based method for gene-set enrichment visualization and interpretation. PloS One 2010, 5:e13984.
29. Merlos-Suarez A., Barriga F.M., Jung P., Iglesias M., Cespedes M.V., Rossell D., Sevillano M., Hernando-Momblona X., da Silva-Diz V., Munoz P., Clevers H., Sancho E., Mangues R., Batlle E. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011, 8:511-524.
30. Mermel C.H., Schumacher S.E., Hill B., Meyerson M.L., Beroukhim R., Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011, 12:R41.
31. Mitra S.A., Mitra A.P., Triche T.J. A central role for long non-coding RNA in cancer. Front. Genet. 2012, 3:17.
32. O'Connell J.B., Maggard M.A., Ko C.Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J.Natl. Cancer Inst. 2004, 96:1420-1425.
33. Pang K.C., Stephen S., Dinger M.E., Engstrom P.G., Lenhard B., Mattick J.S. RNAdb 2.0-an expanded database of mammalian non-coding RNAs. Nucl. Acids Res. 2007, 35:D178-D182.
34. Popat S., Hubner R., Houlston R.S. Systematic review of microsatellite instability and colorectal cancer prognosis. J.Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2005, 23:609-618.
35. Popovici V., Budinska E., Tejpar S., Weinrich S., Estrella H., Hodgson G., Van Cutsem E., Xie T., Bosman F.T., Roth A.D., Delorenzi M. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J.Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2012, 30:1288-1295.
36. Prat A., Perou C.M. Deconstructing the molecular portraits of breast cancer. Molecular Oncol. 2011, 5:5-23.
37. Prensner J.R., Chinnaiyan A.M. The emergence of lncRNAs in cancer biology. Cancer discovery 2011, 1:391-407.
38. Prensner J.R., Iyer M.K., Balbin O.A., Dhanasekaran S.M., Cao Q., Brenner J.C., Laxman B., Asangani I.A., Grasso C.S., Kominsky H.D., Cao X., Jing X., Wang X., Siddiqui J., Wei J.T., Robinson D., Iyer H.K., Palanisamy N., Maher C.A., Chinnaiyan A.M. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nature Biotechnol. 2011, 29:742-749.
39. Qi P., Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Modern Pathol.: Off. J. U.S. Canad. Acad. Pathol. Inc. 2013, 26:155-165.
40. Reis-Filho J.S., Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. The Lancet 2011, 378:1812-1823.
41. Risueno A., Fontanillo C., Dinger M.E., De Las Rivas J. GATExplorer: genomic and transcriptomic explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs. BMC Bioinform. 2010, 11:221.
42. Roth A.D., Tejpar S., Delorenzi M., Yan P., Fiocca R., Klingbiel D., Dietrich D., Biesmans B., Bodoky G., Barone C., Aranda E., Nordlinger B., Cisar L., Labianca R., Cunningham D., Van Cutsem E., Bosman F. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J.Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 2010, 28:466-474.
43. Rousseeuw P.J. Silhouettes: a graphical aid to the interpretation and validation of cluster analysis. J.Comput. Appl. Mathem. 1987, 20:53-65.
44. Sadanandam A., Lyssiotis C.A., Homicsko K., Collisson E.A., Gibb W.J., Wullschleger S., Ostos L.C., Lannon W.A., Grotzinger C., Del Rio M., Lhermitte B., Olshen A.B., Wiedenmann B., Cantley L.C., Gray J.W., Hanahan D. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nat. Med. 2013, 19:619-625.
45. Sanz-Pamplona R., Berenguer A., Cordero D., Riccadonna S., Sole X., Crous-Bou M., Guino E., Sanjuan X., Biondo S., Soriano A., Jurman G., Capella G., Furlanello C., Moreno V. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review. PloS One 2012, 7:e48877.
46. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA: A Cancer J. Clinic. 2014, 64:9-29.
47. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:15545-15550.
48. Tibshirani R., Hastie T., Narasimhan B., Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:6567-6572.
49. Tinzl M., Marberger M., Horvath S., Chypre C. DD3PCA3 RNA analysis in urine-a new perspective for detecting prostate cancer. Eur. Urol. 2004, 46:182-186. Discussion 187.
50. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5116-5121.
51. Vermeulen L., De Sousa E.M.F., van der Heijden M., Cameron K., de Jong J.H., Borovski T., Tuynman J.B., Todaro M., Merz C., Rodermond H., Sprick M.R., Kemper K., Richel D.J., Stassi G., Medema J.P. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nature Cell Biol. 2010, 12:468-476.
52. Villegas V.E., Rahman M.F., Fernandez-Barrena M.G., Diao Y., Liapi E., Sonkoly E., Stahle M., Pivarcsi A., Annaratone L., Sapino A., Ramirez Clavijo S., Burglin T.R., Shimokawa T., Ramachandran S., Kapranov P., Fernandez-Zapico M.E., Zaphiropoulos P.G. Identification of novel non-coding RNA-based negative feedback regulating the expression of theoncogenic transcription factor GLI1. Molecular Oncol 2014, 8:912-926.
53. Walther A., Houlston R., Tomlinson I. Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 2008, 57:941-950.
54. Wang X., Markowetz F., De Sousa E.M.F., Medema J.P., Vermeulen L. Dissecting cancer heterogeneity-an unsupervised classification approach. Int. J. Biochem. Cell Biol. 2013, 45:2574-2579.
55. Weigelt B., Baehner F.L., Reis-Filho J.S. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J.Pathol. 2010, 220:263-280.